Skip to main content
. 2023 Dec 14;11:1269194. doi: 10.3389/fpubh.2023.1269194

Figure 2.

Figure 2

The estimated effectiveness of inactivated COVID-19 vaccines against symptomatic SARS-CoV-2 infections caused by Omicron BA.2. Unadjusted (A) and adjusted (B) logistic conditional model by age group (3–17 years, 18–64 years and older than 65 years) and gender (male and female) to estimated vaccine effectiveness by various intervals.